Quick Answer
HARVARD BIOSCIENCE INC reported Stockholders Equity of $13.73 million for the year ending 2025.
- HARVARD BIOSCIENCE INC showed a decrease of -78.3% in Stockholders Equity from 2024 to 2025.
- This data is from HARVARD BIOSCIENCE INC's annual report (Form 10-K), filed with the SEC on March 13, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2012: $98.11 million | Q2 2012: $98.02 million | Q3 2012: $100.36 million | Q1 2013: $104.38 million | Q2 2013: $105.38 million | Q3 2013: $107.84 million | Q1 2014: $96.18 million | Q2 2014: $98.23 million | Q3 2014: $96.78 million | Q1 2015: $90.50 million | Q2 2015: $94.81 million | Q3 2015: $94.29 million | Q1 2016: $78.20 million | Q2 2016: $76.66 million | Q3 2016: $75.89 million | Q1 2017: $72.72 million | Q2 2017: $75.21 million | Q3 2017: $76.91 million | Q1 2018: $79.29 million | Q2 2018: $77.01 million | Q3 2018: $80.96 million | Q1 2019: $80.35 million | Q2 2019: $80.33 million | Q3 2019: $77.10 million | Q1 2020: $76.01 million | Q2 2020: $76.07 million | Q3 2020: $77.17 million | Q1 2021: $77.12 million | Q2 2021: $78.70 million | Q3 2021: $76.89 million | Q1 2022: $76.38 million | Q2 2022: $77.50 million | Q3 2022: $71.98 million | Q1 2023: $74.34 million | Q2 2023: $75.39 million | Q3 2023: $74.29 million | Q1 2024: $68.81 million | Q2 2024: $67.25 million | Q3 2024: $65.32 million | Q1 2025: $14.84 million | Q2 2025: $15.73 million | Q3 2025: $14.07 million.
- Over the full 17 years of available data (2009 to 2025), HARVARD BIOSCIENCE INC's Stockholders Equity has declined by 81.8%.
- Historical annual values: Fiscal year 2025: $13.73 million | Fiscal year 2024: $63.34 million | Fiscal year 2023: $73.07 million | Fiscal year 2022: $72.22 million | Fiscal year 2021: $83.40 million | Fiscal year 2020: $76.68 million | Fiscal year 2019: $81.69 million | Fiscal year 2018: $82.72 million | Fiscal year 2017: $80.90 million | Fiscal year 2016: $72.20 million | Fiscal year 2015: $77.60 million | Fiscal year 2014: $95.47 million | Fiscal year 2013: $94.49 million | Fiscal year 2012: $104.21 million | Fiscal year 2011: $95.50 million | Fiscal year 2010: $90.25 million | Fiscal year 2009: $75.26 million.
- Data sourced from SEC EDGAR public filings as of August 6, 2026.
Last verified: